Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $65.5500 (-1.68%) ($65.4800 - $66.9500) on Wed. Feb. 7, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.25% (three month average) | RSI | 40 | Latest Price | $65.5500(-1.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -1.9% a day on average for past five trading days. | Weekly Trend | BAX declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(58%) SPLV(53%) VYM(52%) XLP(51%) IVE(50%) | Factors Impacting BAX price | BAX will decline at least -0.625% in a week (0% probabilities). TLT(-19%) VIXM(-16%) GDXJ(-9%) UUP(-6%) DIA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.625% (StdDev 1.25%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
Resistance Level | $69.27 | 5 Day Moving Average | $67.25(-2.53%) | 10 Day Moving Average | $69.39(-5.53%) | 20 Day Moving Average | $69.27(-5.37%) | To recent high | -9.3% | To recent low | 3.2% | Market Cap | $33.442b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |